TI
IHE icon

tru Independence’s iShares US Pharmaceuticals ETF IHE Stock Holding History

tru Independence’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-180
Closed -$8K – 800
2019
Q4 		$8K Buy
+180
New +$8.87K ﹤0.01% 596

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

tru Independence's IHE Position: Q1 2020 in Review

tru Independence sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2020, closing a stake of 180 shares — an estimated $8K sold.

tru Independence first reported a position in IHE in Q4 2019 and held it in 1 quarter. The position peaked at $8K in Q4 2019. 92 funds tracked by Wall St. Rank hold IHE as of Q1 2020.

  • tru Independence reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
  • tru Independence sold 180 iShares US Pharmaceuticals ETF shares in Q1 2020, an estimated $8K.
  • tru Independence first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and held it in 1 quarter.
  • tru Independence's iShares US Pharmaceuticals ETF position peaked at $8K in Q4 2019.
  • 92 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2020.

Based on tru Independence's 13F filing for Q1 2020, filed 19 May 2020.